文献速递临床试验与 GCP新药、器械与细胞基因治疗研发

碱化尿液对痛风患者肾结石影响的安慰剂对照双盲随机试验方案

Effect of alkalized urine on renal calculi in patients with gout: a protocol for a placebo-controlled, double-blinded randomized controlled trial.
PubMed 文献 · Trials · 2021-10-26

本研究为安慰剂对照双盲随机试验方案,纳入痛风合并肾结石患者,1:1随机分为碳酸氢钠组和安慰剂组,干预24周(前12周双盲,后12周开放),所有受试者均服用非布司他40 mg/日。主要结局为治疗12周后肾结石体积减小的患者比例,旨在评估碱化尿液对肾结石的疗效与安全性。

要点

  • 痛风合并肾结石患者随机接受碳酸氢钠(1 g tid)或安慰剂,前12周双盲。
  • 所有受试者均服用非布司他40 mg/日并接受12周抗炎预防治疗。
  • 主要结局为12周后肾结石体积减小的患者比例。

核心结论

  • 本试验将评估碳酸氢钠碱化尿液对痛风患者肾结石的疗效与安全性。

研究设计与样本

  • 随机、安慰剂对照、双盲试验方案,痛风合并肾结石患者按1:1随机分组。
  • 干预24周,其中1-12周双盲,13-24周开放标签。
  • 碳酸氢钠组接受碳酸氢钠1 g tid共24周;安慰剂组前12周接受安慰剂,13-24周不给予安慰剂。
  • 所有受试者均接受非布司他40 mg/日共24周,并接受12周抗炎预防治疗。

关键数值与推荐

  • 主要结局为治疗12周后肾结石体积减小的患者比例。
  • 次要结局包括12周和24周后肾结石体积变化、尿酸变化、血清尿酸(sUA)< 360 μmol/L的患者比例、估算肾小球滤过率(eGFR)变化、尿液pH值及不良事件发生率。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The prevalence of renal calculi in patients with gout is high. Alkalized urine has been recommended by the 2020 European Association of Urology (EAU) guidelines to promote calculus dissolution. However, randomized controlled trials are lacking. METHODS: In the protocol of this randomized, placebo-controlled, double-blinded trial, patients with gout combined with renal calculi are randomized (1:1) to the placebo and sodium bicarbonate groups. The intervention would be performed for 24 weeks, the 1-12 weeks are double-blinded, and the 13-24 weeks are open-labeled. Sodium bicarbonate (1 g tid) will be performed for 24 weeks in the sodium bicarbonate group. The placebo will be performed for 12 weeks and not be performed from 13 weeks to 24 weeks in the placebo group. All subjects will be administered febuxostat (40 mg/day) for 24 weeks and receive concomitant anti-inflammatory prophylaxis therapy for 12 weeks. The primary outcome is the proportion of patients whose renal calculus volume will be reduced after 12 weeks of treatment. The secondary outcomes include the volume changes of renal calculi, uric acid changes, the proportion of patients with serum uric acid (sUA) levels < 360 μmol/L, the changes in estimated glomerular filtration rate (eGFR), the pH value of urine, and the incidence of adverse events after treatment for 12 and 24 weeks. DISCUSSION: This study will evaluate the efficacy and safety of sodium bicarbonate-alkalized urine on renal calculi in patients with gout. TRIAL REGISTRATION: ClinicalTrials.gov ChiCTR2100045183. Registered on April 7, 2021, with ChiCTR.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Jia E, Zhu H, Geng H, et al. Effect of alkalized urine on renal calculi in patients with gout: a protocol for a placebo-controlled, double-blinded randomized controlled trial. Trials. 2021. PMID: 34702311. doi:10.1186/s13063-021-05721-8

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。